Myocyte death in heart failure

Current Opinion in Cardiology

Volumn 11, Issue 3, 1996, Pages 245-251

  Anversa, Piero ^a   Kajstura, Jan ^b   Olivetti, Giorgio ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL DEATH; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; CARDIOMEGALY; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; VENTRICULAR DYSFUNCTION;

EID: 0029889712     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199605000-00004     Document Type: Review

References (55)

1. Anversa P, Olivetti G, Meggs LG, Sonnenblick EH, Capasso JM: Cardiac anatomy and ventricular loading after myocardial infarction. Circulation 1993 87(Suppl 7):22-26.
2. Grossman W, Carabello BA, Gunther S, Fifer MA: Ventricular wall stress and the development of cardiac hypertrophy and failure. In Perspectives in Cardiovascular Research: Myocardial Hypertrophy and Failure. Edited by Alpert MR. New York: Raven Press Publishers; 1983:1-18.
3. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
4. Linzbach AJ: Heart failure from the point of view of quantitative anatomy. Am J Cardiol 1960, 5:370-382.
5. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P: Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994, 89:151-163.
6. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, Schunkert H, Benedict CR, Lorell BH: Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994, 90:1410-1422.
7. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P: The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995, 27:291-305.
8. Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE: Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation 1995, 91:802-812.
9. Spinale FG, Holzgrefe HH, Mukherjee R, Hird RB, Walker JD, Arnim-Barker A, Powell JR, Koster WH: Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy: effects on left ventricular and myocyte structure and function. Circulation 1995, 92:562-578.
10. Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, Hintze TH, Anversa P: The cellular basis of pacing-induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995, 92:2306-2317.
11. Kajstura J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C, Cheng W, Darzynkiewicz Z, Olivetti G, Anversa P: Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing induced cardiomyopathy in rats. Circ Res 1994, 74:383-400.
12. Quaini F, Cigola E, Lagrasta C, Saccani G, Quaini E, Rossi C, Olivetti G, Anversa P: End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen (PCNA) and nuclear mitotic division in ventricular myocytes. Circ Res 1994, 75:1050-1063.
13. Wei JY: Age and the cardiovascular system. N Engl J Med 1992, 237:1735-1739.
14. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P: Gender differences and aging: effects on the human heart J Am Coll Cardiol 1995, 26:1068-1079.
15. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI: Collagen remodeling of the pressure overloaded, hypertrophied nonhuman primate myocardium. Circ Res 1988, 62:757-765.
16. Bing OHL, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH: The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 1995, 27:383-396.
17. Spinale FG, Zellner JL, Tomita M, Crawford FA, Ziles MR: Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res 1991, 69:1058-1067.
18. Gottlieb RA, Burleson KO, Kloner RA, Bablor BM, Engler RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994, 94:1621-1628. First documentation of apoptotic myocyte cell death in the rabbit heart subjected to ischemia-reperfusion injury.
19. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed JC, Quaini F, Sonnenblick EH, Anversa P: Programmed cell death and the expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp Cell Res 1995, 219:110-121.
20. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Jie T, Ito K: DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 1995, 146:1325-1331. Programmed myocyte cell death has been shown to occur in the infarcted portion of the heart in humans.
21. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM: Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A 1995, 92:8031-8035. Insulin-like growth factor I appears to protect from apoptotic and necrotic myocyte cell death induced by ischemia followed by reperfusion.
22. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P: Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995, 73:771-787. Demonstration that myocyte proliferation and apoptotic myocyte death may simultaneously occur in the failing heart.
23. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P: Apoptotic and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest 1995, 74:86-107. Experimental documentation of the relative contribution of apoptotic and necrotic cell death to infarct size in rats.
24. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M: Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994, 75:426-433.
25. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P: Stretch-induced programmed myocyte cell death. J Clin Invest 1995, 96:2247-2259. In vitro documentation that diastolic Laplace overloading triggers apoptotic myocyte cell death and that this phenomenon can be attenuated by nitric oxide.
26. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissue: an overview. Cancer Metastasis Rev 1992, 11:95-103.
27. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13:795-808.
28. Arends MJ, Morris RG, Wyllie AH: Apoptosis: the role of endonuclease. Am J Pathol 1990, 136:593-608.
29. Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, Darzynkiewicz Z: DNA strand breaks occurring during apoptosis: their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int Oncol 1992, 1:639-648.
30. Anversa P, Li P, Zhang X, Olivetti G, Capasso JM: Ischemic myocardial injury and ventricular remodeling. Cardiovasc Res 1993, 27:145-157.
31. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B: Cellular mechanisms of myocardial infarct expansion. Circulation 1988, 78:186-201.
32. Olivetti G, Capasso JM, Sonnenblick EH, Anversa P: Side-to-side slip-page of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res 1990, 67:23-34.
33. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P: Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 1991, 68:856-869.
34. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N: Impairment of myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991, 83:504-514.
35. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849-1865.
36. Whittaker P, Kloner RA: Ventricular remodeling of the heart. Curr Opin Cardiol 1991, 6:346-351.
37. Whittaker P: Unravelling the mysteries of collagen and cicatrix after myocardial infarction. Cardiovasc Res 1995, 29:758-762. Excellent review on the role of collagen following myocardial infarction.
38. Booz GW, Baker KM: Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 1995, 30:537-543. Excellent review on the regulatory control mechanisms of fibroblast growth in the heart.
39. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA: Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989, 67:657-670.
40. Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984, 142:67-77.
41. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined used of in situ tailing and nick translation techniques. Lab Invest 1994, 71:219-225.
42. Nolan AC, Clark WA, Karwoski T, Zak R: Patterns of cellular injury in myocardial ischemia determined by monoclonal antimyosin. Proc Natl Acad Sci U S A 1983, 80:6046-6050.
43. Gerschenson LE, Rotello RJ: Apoptosis: a different type of cell death. FASEB J 1992, 6:2450-2455.
44. Kerr JFR, Winterford CM, Harmon BV: Apoptosis: its significance in cancer and cancer therapy. Cancer 1994, 73:2013-2026.
45. Pfeffer JM, Pfeffer MA, Braunwald E: Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985, 57:84-95.
46. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991, 69:475-482.
47. Meggs LG, Coupet J, Huang H, Cheng W, Li P, Capasso JM, Homcy CJ, Anversa P: Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res 1993, 72:1149-1162.
48. Zhang X, Dostal DE, Reiss K, Cheng W, Kajstura J, Li P, Huang H, Sonnenblick EH, Meggs LG, Baker KM, Anversa P: Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. Am J Physiol 1995, 269:H1791-H1802. Documentation that adult ventricular myocytes possess the various molecular components of the renin-angiotensin system, which is up-regulated in the presence of cardiac failure.
49. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, Shelton B, for the SOLVD Investigators: Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Circulation 1995, 91:2573-2581.
50. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators: The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995, 332:80-85.
51. Belichard P, Savard P, Cardinal R, Nadeau R, Gosselin H, Paradis P, Rouleau JL: Markedly different effects of ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol 1994, 23:505-513.
52. Kabour A, Henegar JR, Devineni VR, Janicki JS: Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat Cardiovasc Res 1995, 29:543-548. Angiotensin-converting enzyme inhibition attenuates the effects of angiotensin II on myocyte necrosis and vascular damage in rats.
53. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT: Cardiac angiotensin enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994, 28:1423-1432.
54. Reiss K, Cheng W, Kajstura J, Sonnenblick EH, Meggs LG, Anversa P: Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors. Am J Physiol 1995, 269:H943-H951. Insulin-like growth factor I appears to be a major modulator of fibroblast proliferation in the heart.
55. Jaskulski D, DeReil JK, Mercer WE, Calabretta B, Baserga R: Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science 1988, 140:1544-1546.